Status:

RECRUITING

Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis (CRS).

Lead Sponsor:

Region Skane

Conditions:

Chronic Rhinosinusitis Without Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

Chronic rhinosinusitis (CRS) is a disease associated with impaired quality of life and substantial societal costs. Much is still uncertain regarding the underlying etiology of the disease. Current tre...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (CRS-Patients):
  • 2 nasal symptoms, 1 of which must be nasal obstruction or discolored discharge.
  • Sinusitis verified by endoscopy or CT scan
  • Duration \> 12 weeks.
  • Signed informed consent to participate in the study.
  • Exclusion Criteria (CRS-Patients):
  • Antibiotic treatment in the last 3 months before study start.
  • Ongoing or recent participation in another clinical trial.
  • Any medication that might affect the results in an unpredictable manner.
  • Treatment with monoclonal antibodies (biologics).
  • Immunodeficiency other than low grade MBL deficiency.
  • Pregnancy or breastfeeding
  • Severe anatomical abnormalities.
  • SNOT 22 \< 20.
  • Inclusion Criteria (Donors):
  • No history of sinonasal or lower airway disease within the last two years other than the common cold.
  • Accepted as a donor by the patient.
  • Signed informed consent to participate in the study.
  • Exclusion Criteria (CRS-Patients):
  • Chronic rhinosinusitis.
  • Acute rhinosinusitis within the last two years.
  • Nasal polyposis
  • Antibiotic treatment within the last 3 months before the study start.
  • On going or recent participation in another clinical trial.
  • Findings in the pre study scan that makes the donor unsuitable.

Exclusion

    Key Trial Info

    Start Date :

    October 14 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    February 1 2031

    Estimated Enrollment :

    50 Patients enrolled

    Trial Details

    Trial ID

    NCT07184684

    Start Date

    October 14 2024

    End Date

    February 1 2031

    Last Update

    September 22 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Departement of ORL

    Helsingborg, Sweden, 25187